Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Pediatric antidepressant use after the black-box warning.

Busch SH, Barry CL.

Health Aff (Millwood). 2009 May-Jun;28(3):724-33. doi: 10.1377/hlthaff.28.3.724.

2.

Pediatric prescribing practices and the FDA Black-box warning on antidepressants.

Cheung A, Sacks D, Dewa CS, Pong J, Levitt A.

J Dev Behav Pediatr. 2008 Jun;29(3):213-5. doi: 10.1097/DBP.0b013e31817bd7c9.

PMID:
18550990
3.

A black-box warning for antidepressants in children?

Newman TB.

N Engl J Med. 2004 Oct 14;351(16):1595-8. No abstract available.

PMID:
15483275
4.

Antidepressants and suicidality: the basis of controversies.

Marcinko D.

Psychiatr Danub. 2007 Sep;19(3):238-40.

PMID:
17914327
5.

The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses.

Leon AC.

Am J Psychiatry. 2007 Dec;164(12):1786-9. No abstract available.

PMID:
18056231
6.

The black box warning: decreased prescriptions and increased youth suicide?

Jureidini J.

Am J Psychiatry. 2007 Dec;164(12):1907; author reply 1908-10. No abstract available.

PMID:
18056248
7.

Antidepressants and children's depression.

Diller L.

Am J Psychiatry. 2005 Jun;162(6):1226-7. No abstract available.

PMID:
15930080
8.

SSRI prescriptions and the rate of suicide.

Olfson M, Shaffer D.

Am J Psychiatry. 2007 Dec;164(12):1907-8; author reply 1908-10. No abstract available.

PMID:
18056247
9.

Antidepressants and pediatric depression--the risk of doing nothing.

Brent DA.

N Engl J Med. 2004 Oct 14;351(16):1598-601. No abstract available.

PMID:
15483276
10.

[The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].

Plener PL, Fegert JM, Kölch MG.

Z Kinder Jugendpsychiatr Psychother. 2012 Nov;40(6):365-71. doi: 10.1024/1422-4917/a000196. Review. German.

PMID:
23109125
11.

Antidepressants use in pediatric populations.

Gören JL.

Expert Opin Drug Saf. 2008 May;7(3):223-5. doi: 10.1517/14740338.7.3.223 .

PMID:
18462180
12.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.

Arch Gen Psychiatry. 2007 Apr;64(4):466-72.

PMID:
17404123
13.

Antidepressants' black-box warning--10 years later.

Friedman RA.

N Engl J Med. 2014 Oct 30;371(18):1666-8. doi: 10.1056/NEJMp1408480. No abstract available.

14.

Lost in the black box: juvenile depression, suicide, and the FDA's black box.

Rappaport N, Prince JB, Bostic JQ; Association of Medical School Pediatric Department Chairs, Inc.

J Pediatr. 2005 Dec;147(6):719-20. No abstract available.

PMID:
16356415
15.

Youth suicide trends place SSRIs in spotlight.

[No authors listed]

Behav Healthc Tomorrow. 2004 Feb;13(1):42-5. No abstract available.

PMID:
15002199
16.

The FDA warning on antidepressants and suicidality--why the controversy?

Stone MB.

N Engl J Med. 2014 Oct 30;371(18):1668-71. doi: 10.1056/NEJMp1411138. No abstract available.

18.

Expanding the black box - depression, antidepressants, and the risk of suicide.

Friedman RA, Leon AC.

N Engl J Med. 2007 Jun 7;356(23):2343-6. Epub 2007 May 7. No abstract available.

19.

An update on antidepressant use and suicidality in pediatric depression.

Adegbite-Adeniyi C, Gron B, Rowles BM, Demeter CA, Findling RL.

Expert Opin Pharmacother. 2012 Oct;13(15):2119-30. doi: 10.1517/14656566.2012.726613. Review.

PMID:
22984934
20.

Depression, antidepressants and suicidality: a critical appraisal.

Licinio J, Wong ML.

Nat Rev Drug Discov. 2005 Feb;4(2):165-71. Review.

PMID:
15688079

Supplemental Content

Support Center